L'ENREGISTREMENT NUMERIQUE DU SON EN RADIODIFFUSIONWEISSER A.1979; REV. U.E.R., TECH.; BEL; DA. 1979; NO 173; PP. 2-9Article

SAMMELN, ZUM BEISPIELJUGENDSTILKACHELNWEISSER A; WEISSER M.ARTIS. 1976, Vol 28, Num 2, pp 10-13Article

INTERVENTION RAPIDE SUR MATERIELS AUDIO. L'APPAREIL DE MESURE IRMA.WEISSER A.1977; REV. U.E.R., TECH.; BELG.; DA. 1977; NO 161; PP. 14-19Article

THE DIGITAL RECORDING OF SOUND IN BROADCASTINGWEISSER A.1980; S.M.P.T.E.J.; USA; DA. 1980; VOL. 89; NO 7; PP. 520-524Article

PERSISTENCE OF CYTOMEGALOVIRUS IN HUMAN LYMPHOBLASTS AND PERIPHERAL LEUKOCYTE CULTURES.JEOR S ST; WEISSER A.1977; INFECT. AND IMMUN.; U.S.A.; DA. 1977; VOL. 15; NO 2; PP. 402-409; BIBL. 21 REF.Article

Transfer of processes from development to manufacturing : Optimizing pharmaceutical development : The global experienceGERSON, D. F; HIMES, V; HOPFER, R et al.Drug information journal. 1998, Vol 32, Num 1, pp 19-26, issn 0092-8615Conference Paper

Pegylated liposomal doxorubicin in combination with mitomycin C, infusional 5-fluorouracil and sodium folinic acid. A phase-I-study in patients with upper gastrointestinal cancerHOFHEINZ, R-D; WILLER, A; WEISSER, A et al.British journal of cancer. 2004, Vol 90, Num 10, pp 1893-1897, issn 0007-0920, 5 p.Article

Detection and quantification of residual disease in chronic myelogenous leukemiaHOCHHAUS, A; WEISSER, A; CROSSE, N et al.Leukemia. 2000, Vol 14, Num 6, pp 998-1005, issn 0887-6924Article

The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1WALZ, C; CHASE, A; REITER, A et al.Leukemia. 2005, Vol 19, Num 6, pp 1005-1009, issn 0887-6924, 5 p.Article

Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon αMERX, K; MÜLLER, M. C; HEHLMANN, R et al.Leukemia. 2002, Vol 16, Num 9, pp 1579-1583, issn 0887-6924Article

Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCREMIG, M; SAUSSELE, S; WITTOR, H et al.Leukemia. 1999, Vol 13, Num 11, pp 1825-1832, issn 0887-6924Conference Paper

Gene expression profiling of CD34 + cells identifies a molecular signature of chronic myeloid leukemia blast crisisZHENG, C; LI, L; GRETZ, N et al.Leukemia. 2006, Vol 20, Num 6, pp 1028-1034, issn 0887-6924, 7 p.Article

Molecular monitoring of response to imatinib (Glivec®) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission : Spotlight on imatinib as a model for signal transduction inhibitorsPASCHKA, P; MÜLLER, M. C; GSCHAIDMEIER, H et al.Leukemia. 2003, Vol 17, Num 9, pp 1687-1694, issn 0887-6924, 8 p.Article

Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilizationMÜLLER, M. C; MERX, K; WEISSER, A et al.Leukemia. 2002, Vol 16, Num 12, pp 2395-2399, issn 0887-6924, 5 p.Article

Reduced ¹H-NMR visibility of creatine in isolated rat heartsSCHNEIDER, J; FEKETE, E; WEISSER, A et al.Magnetic resonance in medicine. 2000, Vol 43, Num 4, pp 497-502, issn 0740-3194Article